The move could come as early as Thursday.
, including Arkansas, California, Colorado and New Mexico, along with New York City, chose not to wait for the FDA’s official sign off, moving on their own to allow boosters, including Moderna’s, for all adults in the past week.for certain subsets of adults in the U.S.: people ages 65 and up, people living in long-term care facilities and people ages 18 to 64 at high risk of COVID-19 because of their jobs or underlying medical conditions.
All adults who were initially vaccinated with the Johnson & Johnson vaccine are also eligible for booster shots. Moderna has not yet asked the FDA to authorize its booster for all adults; it is limited to older adults and those at high risk.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
Les mer »
Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pillPfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill.
Les mer »
Pfizer agrees to let other companies make its COVID-19 pillDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. “It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
Les mer »
Pfizer Seeks FDA Emergency Use Authorization for Its COVID-19 PillPfizer has signed a deal to allow other manufacturers to make its experimental COVID-19 pill, possibly opening up access to treatment to countries across the world:
Les mer »